CAS: 851095-32-4 - STX-0119
STX-0119
CAS:851095-32-4
STX-0119 is a selective, orally active STAT3 dimerization inhibitor. STX-0119 inhibits STAT3 transcription with an …
Fórmula:
C22H14N4O3
Pureza:
99.42%
Forma y color:
Liquid
Peso molecular:
382.37
Ref: TM-T60160
| 5mg | 63,00 € | ||
| 10mg | 90,00 € | ||
| 25mg | 174,00 € | ||
| 50mg | 277,00 € | ||
| 100mg | 417,00 € | ||
| 500mg | A consultar | ||
| 1mL*10mM (DMSO) | 63,00 € |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
![N-[5-(2-Furanyl)-1,3,4-oxadiazol-2-yl]-2-phenyl-4-quinolinecarboxamide](https://static.cymitquimica.com/products/TR/thumb/F863670.jpg)
N-[5-(2-Furanyl)-1,3,4-oxadiazol-2-yl]-2-phenyl-4-quinolinecarboxamide
Producto controladoCAS:851095-32-4
Fórmula:
C22H14N4O3
Forma y color:
Neat
Peso molecular:
382.37
Ref: TR-F863670
| 100mg | 1.063,00 € |
Entrega estimada en Estados Unidos, el Jueves 16 de Enero de 2025
![N-[5-(Furan-2-yl)-1,3,4-oxadiazol-2-yl]-2-phenylquinoline-4-carboxamide](https://static.cymitquimica.com/products/3D/thumb/BJB09532.jpg)
N-[5-(Furan-2-yl)-1,3,4-oxadiazol-2-yl]-2-phenylquinoline-4-carboxamide
CAS:851095-32-4
Please enquire for more information about N-[5-(Furan-2-yl)-1,3,4-oxadiazol-2-yl]-2-phenylquinoline-4-carboxamide including the price, delivery time and more detailed …
Fórmula:
C22H14N4O3
Pureza:
Min. 95%
Peso molecular:
382.4 g/mol
Ref: 3D-BJB09532
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 17 de Enero de 2025
